| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Water Pollutants, Chemical | 2 | 2025 | 38 | 1.810 |
Why?
|
| Mouth Neoplasms | 2 | 2024 | 115 | 1.560 |
Why?
|
| Zebrafish | 2 | 2025 | 419 | 1.530 |
Why?
|
| Embryo, Nonmammalian | 2 | 2025 | 151 | 1.110 |
Why?
|
| Trans-Activators | 14 | 2021 | 831 | 0.980 |
Why?
|
| Guaiacol | 1 | 2025 | 1 | 0.980 |
Why?
|
| Polysaccharides | 3 | 2021 | 150 | 0.980 |
Why?
|
| Cartilage | 1 | 2025 | 51 | 0.950 |
Why?
|
| Plasticizers | 1 | 2024 | 3 | 0.940 |
Why?
|
| Phthalic Acids | 1 | 2024 | 10 | 0.930 |
Why?
|
| Chondrogenesis | 1 | 2024 | 29 | 0.910 |
Why?
|
| Nuclear Receptor Coactivator 1 | 11 | 2019 | 244 | 0.900 |
Why?
|
| Gracilaria | 2 | 2021 | 2 | 0.900 |
Why?
|
| Methyltransferases | 1 | 2024 | 82 | 0.860 |
Why?
|
| Nuclear Receptor Coactivator 3 | 16 | 2018 | 351 | 0.840 |
Why?
|
| Odorants | 2 | 2020 | 83 | 0.810 |
Why?
|
| Cisplatin | 1 | 2024 | 287 | 0.800 |
Why?
|
| Craniofacial Abnormalities | 1 | 2024 | 250 | 0.800 |
Why?
|
| Reactive Oxygen Species | 2 | 2025 | 526 | 0.790 |
Why?
|
| Carps | 5 | 2019 | 9 | 0.740 |
Why?
|
| Soy Foods | 1 | 2020 | 10 | 0.680 |
Why?
|
| Oxidative Stress | 2 | 2025 | 871 | 0.670 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 873 | 0.670 |
Why?
|
| Insulin-Like Growth Factor I | 8 | 2015 | 352 | 0.670 |
Why?
|
| Animals | 71 | 2025 | 36443 | 0.660 |
Why?
|
| Mice | 59 | 2025 | 18963 | 0.630 |
Why?
|
| Histone Acetyltransferases | 10 | 2008 | 318 | 0.630 |
Why?
|
| Energy Metabolism | 1 | 2024 | 813 | 0.620 |
Why?
|
| Fish Diseases | 4 | 2019 | 11 | 0.620 |
Why?
|
| Colitis | 1 | 2021 | 173 | 0.610 |
Why?
|
| Twist-Related Protein 1 | 6 | 2023 | 39 | 0.590 |
Why?
|
| Mice, Knockout | 27 | 2025 | 3994 | 0.580 |
Why?
|
| Nuclear Proteins | 9 | 2025 | 1339 | 0.570 |
Why?
|
| Head and Neck Neoplasms | 1 | 2023 | 701 | 0.530 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1605 | 0.520 |
Why?
|
| CRISPR-Cas Systems | 4 | 2024 | 296 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2025 | 2123 | 0.470 |
Why?
|
| Mice, Transgenic | 15 | 2024 | 2529 | 0.460 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 1850 | 0.450 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 2 | 2024 | 32 | 0.410 |
Why?
|
| Prostatic Neoplasms | 7 | 2019 | 1623 | 0.390 |
Why?
|
| Cell Differentiation | 10 | 2025 | 2028 | 0.390 |
Why?
|
| Reoviridae | 4 | 2019 | 39 | 0.380 |
Why?
|
| Cell Transformation, Neoplastic | 6 | 2018 | 644 | 0.380 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 3 | 2015 | 56 | 0.380 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 2658 | 0.360 |
Why?
|
| Cell Line, Tumor | 13 | 2025 | 3758 | 0.350 |
Why?
|
| Reoviridae Infections | 3 | 2019 | 8 | 0.350 |
Why?
|
| Mice, Inbred BALB C | 3 | 2024 | 1081 | 0.350 |
Why?
|
| Gene Editing | 3 | 2024 | 213 | 0.340 |
Why?
|
| Fermentation | 2 | 2021 | 71 | 0.340 |
Why?
|
| Taste | 2 | 2020 | 33 | 0.340 |
Why?
|
| Transcription Factors | 13 | 2021 | 2715 | 0.340 |
Why?
|
| Breast Neoplasms | 11 | 2016 | 2768 | 0.340 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2015 | 30 | 0.320 |
Why?
|
| Stem Cells | 5 | 2021 | 752 | 0.300 |
Why?
|
| Phosphoproteins | 3 | 2018 | 458 | 0.290 |
Why?
|
| Cell Movement | 6 | 2025 | 917 | 0.290 |
Why?
|
| Cell Proliferation | 8 | 2025 | 2554 | 0.270 |
Why?
|
| Liver | 4 | 2021 | 1877 | 0.270 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2025 | 469 | 0.260 |
Why?
|
| Mice, Nude | 2 | 2025 | 777 | 0.250 |
Why?
|
| RANK Ligand | 2 | 2025 | 54 | 0.250 |
Why?
|
| Growth Hormone | 1 | 2006 | 151 | 0.250 |
Why?
|
| Cyclin A2 | 1 | 2025 | 5 | 0.240 |
Why?
|
| Coix | 1 | 2025 | 1 | 0.240 |
Why?
|
| Carrageenan | 1 | 2025 | 6 | 0.240 |
Why?
|
| Glutens | 1 | 2025 | 10 | 0.230 |
Why?
|
| Neural Crest | 1 | 2025 | 56 | 0.230 |
Why?
|
| X-linked Nuclear Protein | 1 | 2025 | 19 | 0.230 |
Why?
|
| Repressor Proteins | 5 | 2012 | 869 | 0.230 |
Why?
|
| Triticum | 1 | 2025 | 39 | 0.230 |
Why?
|
| Plant Oils | 1 | 2025 | 37 | 0.230 |
Why?
|
| Seeds | 1 | 2025 | 43 | 0.230 |
Why?
|
| Growth Disorders | 1 | 2006 | 223 | 0.220 |
Why?
|
| Wnt Signaling Pathway | 1 | 2025 | 206 | 0.220 |
Why?
|
| Skull | 1 | 2025 | 146 | 0.220 |
Why?
|
| Sonication | 2 | 2020 | 9 | 0.210 |
Why?
|
| Embryonic Stem Cells | 3 | 2009 | 177 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2015 | 246 | 0.210 |
Why?
|
| Osteoblasts | 1 | 2025 | 164 | 0.210 |
Why?
|
| Male | 32 | 2024 | 65884 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2025 | 251 | 0.210 |
Why?
|
| Hypothalamus | 3 | 2023 | 223 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 392 | 0.200 |
Why?
|
| Serine | 2 | 2016 | 185 | 0.200 |
Why?
|
| Spermatogenesis | 3 | 2015 | 177 | 0.200 |
Why?
|
| Uterus | 4 | 2012 | 585 | 0.200 |
Why?
|
| Oocytes | 2 | 2024 | 302 | 0.190 |
Why?
|
| Mammary Glands, Animal | 7 | 2013 | 477 | 0.190 |
Why?
|
| Signal Transduction | 9 | 2021 | 4912 | 0.190 |
Why?
|
| Cyprinidae | 1 | 2021 | 3 | 0.190 |
Why?
|
| Hypoglycemia | 1 | 2023 | 193 | 0.190 |
Why?
|
| Phenylalanine Hydroxylase | 1 | 2021 | 12 | 0.180 |
Why?
|
| Neuronal Plasticity | 1 | 2024 | 288 | 0.180 |
Why?
|
| Phenylketonurias | 1 | 2021 | 14 | 0.180 |
Why?
|
| Sargassum | 1 | 2021 | 1 | 0.180 |
Why?
|
| Cloning, Molecular | 2 | 2018 | 911 | 0.180 |
Why?
|
| Insulin-Secreting Cells | 2 | 2015 | 150 | 0.180 |
Why?
|
| Citrus | 1 | 2020 | 7 | 0.180 |
Why?
|
| Phenylalanine | 1 | 2021 | 134 | 0.180 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 62 | 0.180 |
Why?
|
| Glycoside Hydrolases | 1 | 2020 | 17 | 0.180 |
Why?
|
| Neuroendocrine Cells | 1 | 2021 | 10 | 0.180 |
Why?
|
| Memory | 1 | 2024 | 358 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2021 | 824 | 0.170 |
Why?
|
| Fatty Acids, Volatile | 1 | 2021 | 47 | 0.170 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2017 | 141 | 0.170 |
Why?
|
| Zygosaccharomyces | 1 | 2020 | 1 | 0.170 |
Why?
|
| Enterococcaceae | 1 | 2020 | 1 | 0.170 |
Why?
|
| Neoplasm Invasiveness | 5 | 2017 | 669 | 0.170 |
Why?
|
| Female | 39 | 2024 | 71644 | 0.170 |
Why?
|
| Neoplasms | 4 | 2023 | 3029 | 0.170 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2020 | 85 | 0.170 |
Why?
|
| Epithelial-Mesenchymal Transition | 5 | 2025 | 248 | 0.170 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 690 | 0.170 |
Why?
|
| Estradiol | 4 | 2015 | 558 | 0.170 |
Why?
|
| Obesity, Morbid | 1 | 2022 | 213 | 0.160 |
Why?
|
| HEK293 Cells | 6 | 2022 | 815 | 0.160 |
Why?
|
| Galectin 1 | 1 | 2019 | 2 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 168 | 0.160 |
Why?
|
| Osteoclasts | 2 | 2025 | 74 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2021 | 105 | 0.160 |
Why?
|
| Apoptosis | 7 | 2018 | 1937 | 0.160 |
Why?
|
| Humans | 33 | 2025 | 133748 | 0.160 |
Why?
|
| Macrophage Colony-Stimulating Factor | 3 | 2014 | 22 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 1919 | 0.160 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2019 | 9 | 0.160 |
Why?
|
| Fertilization in Vitro | 1 | 2020 | 161 | 0.160 |
Why?
|
| Neoplasm Metastasis | 3 | 2015 | 746 | 0.150 |
Why?
|
| Trachea | 1 | 2021 | 212 | 0.150 |
Why?
|
| Submandibular Gland | 1 | 2018 | 6 | 0.150 |
Why?
|
| Hypoxia | 1 | 2021 | 268 | 0.150 |
Why?
|
| Androgens | 2 | 2018 | 297 | 0.150 |
Why?
|
| Serpins | 1 | 2018 | 34 | 0.150 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 1070 | 0.150 |
Why?
|
| Integrin beta1 | 1 | 2018 | 56 | 0.150 |
Why?
|
| Embryonic Development | 1 | 2020 | 222 | 0.150 |
Why?
|
| Organ Specificity | 3 | 2013 | 444 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 650 | 0.150 |
Why?
|
| Glucose | 1 | 2023 | 925 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1163 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2018 | 60 | 0.150 |
Why?
|
| Histone Demethylases | 1 | 2018 | 44 | 0.150 |
Why?
|
| RNA, Long Noncoding | 1 | 2021 | 247 | 0.150 |
Why?
|
| Nuclear Receptor Coactivators | 4 | 2015 | 76 | 0.150 |
Why?
|
| Epithelial Cells | 5 | 2018 | 936 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2020 | 625 | 0.150 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 315 | 0.150 |
Why?
|
| Crosses, Genetic | 4 | 2019 | 170 | 0.150 |
Why?
|
| Transcription Factor AP-1 | 2 | 2015 | 111 | 0.140 |
Why?
|
| DNA, Single-Stranded | 1 | 2018 | 76 | 0.140 |
Why?
|
| Morphogenesis | 3 | 2018 | 215 | 0.140 |
Why?
|
| Colon | 1 | 2021 | 379 | 0.140 |
Why?
|
| Cardiomegaly | 1 | 2018 | 138 | 0.140 |
Why?
|
| RNA, Messenger | 7 | 2012 | 2902 | 0.140 |
Why?
|
| Th17 Cells | 1 | 2018 | 101 | 0.140 |
Why?
|
| Prealbumin | 2 | 2008 | 27 | 0.140 |
Why?
|
| Cell Plasticity | 1 | 2017 | 36 | 0.130 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 160 | 0.130 |
Why?
|
| Oxygen | 1 | 2021 | 582 | 0.130 |
Why?
|
| Feces | 1 | 2021 | 788 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2015 | 211 | 0.130 |
Why?
|
| Prognosis | 2 | 2025 | 5073 | 0.130 |
Why?
|
| Immunity, Innate | 1 | 2019 | 416 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 878 | 0.130 |
Why?
|
| Neurons | 3 | 2024 | 2047 | 0.130 |
Why?
|
| Fishes | 1 | 2016 | 41 | 0.130 |
Why?
|
| RNA, Viral | 1 | 2018 | 563 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 350 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 455 | 0.130 |
Why?
|
| Obesity | 3 | 2022 | 2433 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 352 | 0.120 |
Why?
|
| Estrogens | 2 | 2012 | 523 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 51 | 0.120 |
Why?
|
| MafB Transcription Factor | 1 | 2015 | 1 | 0.120 |
Why?
|
| Maf Transcription Factors, Large | 1 | 2015 | 2 | 0.120 |
Why?
|
| Sexual Behavior, Animal | 1 | 2015 | 88 | 0.120 |
Why?
|
| Lung Neoplasms | 4 | 2017 | 1783 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 8 | 2011 | 4851 | 0.120 |
Why?
|
| Receptors, Estrogen | 4 | 2009 | 829 | 0.120 |
Why?
|
| Transcription, Genetic | 5 | 2015 | 1758 | 0.120 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2016 | 126 | 0.120 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 357 | 0.120 |
Why?
|
| Protein Binding | 5 | 2021 | 1847 | 0.110 |
Why?
|
| Cytokines | 1 | 2021 | 1397 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2013 | 5 | 0.110 |
Why?
|
| Leptin | 2 | 2019 | 224 | 0.110 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 139 | 0.110 |
Why?
|
| Neuroendocrine Tumors | 1 | 2014 | 55 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 263 | 0.110 |
Why?
|
| Bufanolides | 1 | 2014 | 17 | 0.110 |
Why?
|
| Myocytes, Cardiac | 2 | 2018 | 674 | 0.110 |
Why?
|
| Serotonin 5-HT2 Receptor Agonists | 2 | 2024 | 15 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 260 | 0.110 |
Why?
|
| Gene Expression | 6 | 2013 | 1616 | 0.110 |
Why?
|
| Body Weight | 4 | 2019 | 1038 | 0.110 |
Why?
|
| Embryo Implantation | 2 | 2012 | 234 | 0.110 |
Why?
|
| Gene Knockout Techniques | 4 | 2018 | 138 | 0.110 |
Why?
|
| Hair Follicle | 1 | 2013 | 35 | 0.100 |
Why?
|
| Health | 1 | 2013 | 38 | 0.100 |
Why?
|
| Myocardium | 1 | 2018 | 1045 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2021 | 240 | 0.100 |
Why?
|
| Reproduction | 1 | 2015 | 245 | 0.100 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2012 | 37 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2025 | 950 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 447 | 0.100 |
Why?
|
| Serotonin | 2 | 2024 | 226 | 0.100 |
Why?
|
| Cell Line | 5 | 2021 | 2844 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 212 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 382 | 0.090 |
Why?
|
| Receptors, Androgen | 4 | 2019 | 433 | 0.090 |
Why?
|
| Mice, SCID | 3 | 2019 | 613 | 0.090 |
Why?
|
| Receptors, Somatotropin | 1 | 2011 | 9 | 0.090 |
Why?
|
| Phylogeny | 3 | 2019 | 785 | 0.090 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Liver Regeneration | 1 | 2011 | 40 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2015 | 717 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 97 | 0.090 |
Why?
|
| Aging | 3 | 2015 | 1301 | 0.090 |
Why?
|
| Embryo, Mammalian | 3 | 2018 | 466 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 115 | 0.090 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 15 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 516 | 0.080 |
Why?
|
| Receptor, ErbB-2 | 2 | 2011 | 559 | 0.080 |
Why?
|
| Lactation | 1 | 2011 | 199 | 0.080 |
Why?
|
| Fertility | 1 | 2012 | 268 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 25 | 0.080 |
Why?
|
| MCF-7 Cells | 3 | 2015 | 233 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2003 | 592 | 0.080 |
Why?
|
| Hydroxycholecalciferols | 1 | 2009 | 6 | 0.080 |
Why?
|
| Cell Division | 4 | 2004 | 773 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 303 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 1327 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 1763 | 0.080 |
Why?
|
| Cells, Cultured | 5 | 2018 | 3177 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2010 | 132 | 0.080 |
Why?
|
| Gene Deletion | 3 | 2021 | 809 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 2166 | 0.070 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 97 | 0.070 |
Why?
|
| Fish Proteins | 2 | 2019 | 6 | 0.070 |
Why?
|
| Exons | 2 | 2018 | 834 | 0.070 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 141 | 0.070 |
Why?
|
| Disease Progression | 5 | 2018 | 2240 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 281 | 0.070 |
Why?
|
| RNA Interference | 3 | 2015 | 544 | 0.070 |
Why?
|
| Immunoblotting | 3 | 2015 | 318 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2021 | 400 | 0.070 |
Why?
|
| Dwarfism | 1 | 2008 | 102 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 289 | 0.070 |
Why?
|
| Chromatin | 2 | 2018 | 614 | 0.070 |
Why?
|
| Alleles | 3 | 2019 | 1710 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2009 | 277 | 0.070 |
Why?
|
| Heterozygote | 3 | 2019 | 720 | 0.070 |
Why?
|
| Pregnancy | 5 | 2020 | 7545 | 0.060 |
Why?
|
| Infertility, Male | 1 | 2009 | 290 | 0.060 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 80 | 0.060 |
Why?
|
| Histones | 1 | 2009 | 569 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 499 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2009 | 1069 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 226 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 489 | 0.060 |
Why?
|
| Osteoprotegerin | 1 | 2025 | 13 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2025 | 13 | 0.060 |
Why?
|
| Emulsions | 1 | 2025 | 70 | 0.060 |
Why?
|
| Protein Interaction Maps | 1 | 2025 | 90 | 0.060 |
Why?
|
| Gels | 1 | 2025 | 72 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2015 | 59 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 572 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 802 | 0.060 |
Why?
|
| Bone Development | 1 | 2025 | 60 | 0.060 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2004 | 98 | 0.060 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 88 | 0.060 |
Why?
|
| Hot Temperature | 1 | 2025 | 148 | 0.060 |
Why?
|
| Testis | 2 | 2004 | 433 | 0.050 |
Why?
|
| Zygote | 1 | 2024 | 31 | 0.050 |
Why?
|
| Insulin | 1 | 2009 | 1258 | 0.050 |
Why?
|
| Cell Count | 2 | 2021 | 241 | 0.050 |
Why?
|
| Sertoli Cells | 1 | 2004 | 80 | 0.050 |
Why?
|
| Genes, ras | 1 | 2004 | 102 | 0.050 |
Why?
|
| Genotype | 3 | 2008 | 2805 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2006 | 310 | 0.050 |
Why?
|
| Growth | 1 | 2004 | 106 | 0.050 |
Why?
|
| Anoctamins | 1 | 2023 | 14 | 0.050 |
Why?
|
| Tumor Burden | 2 | 2015 | 257 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4796 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2023 | 29 | 0.050 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2024 | 81 | 0.050 |
Why?
|
| Rats | 2 | 2021 | 3885 | 0.050 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 21 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 343 | 0.050 |
Why?
|
| Gene Targeting | 3 | 2013 | 185 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2015 | 834 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2002 | 92 | 0.050 |
Why?
|
| DNA Methylation | 2 | 2020 | 1145 | 0.050 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 276 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 221 | 0.050 |
Why?
|
| Mutation | 3 | 2024 | 6295 | 0.050 |
Why?
|
| Homeostasis | 2 | 2019 | 747 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 96 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2025 | 397 | 0.050 |
Why?
|
| Carotid Artery Injuries | 1 | 2002 | 38 | 0.050 |
Why?
|
| Tunica Intima | 1 | 2002 | 57 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2011 | 1707 | 0.050 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 155 | 0.050 |
Why?
|
| Acetylgalactosamine | 1 | 2021 | 11 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 317 | 0.050 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 107 | 0.050 |
Why?
|
| Microscopy, Atomic Force | 1 | 2021 | 19 | 0.050 |
Why?
|
| Photolysis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Acetylation | 1 | 2021 | 184 | 0.050 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2021 | 26 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2002 | 612 | 0.040 |
Why?
|
| Viscosity | 1 | 2021 | 42 | 0.040 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2021 | 39 | 0.040 |
Why?
|
| Prolyl Hydroxylases | 1 | 2021 | 3 | 0.040 |
Why?
|
| Chromosomes | 1 | 2021 | 164 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2021 | 15 | 0.040 |
Why?
|
| Purkinje Cells | 1 | 2003 | 166 | 0.040 |
Why?
|
| Lactobacillus | 1 | 2021 | 48 | 0.040 |
Why?
|
| Flavoring Agents | 1 | 2020 | 4 | 0.040 |
Why?
|
| Calcitonin Receptor-Like Protein | 1 | 2021 | 22 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2021 | 119 | 0.040 |
Why?
|
| Superovulation | 1 | 2020 | 12 | 0.040 |
Why?
|
| Prebiotics | 1 | 2021 | 29 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2021 | 198 | 0.040 |
Why?
|
| Aspergillus niger | 1 | 2020 | 21 | 0.040 |
Why?
|
| Molecular Weight | 1 | 2021 | 388 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 870 | 0.040 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 25 | 0.040 |
Why?
|
| Particle Size | 1 | 2021 | 148 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 61 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 787 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2020 | 164 | 0.040 |
Why?
|
| Blastocyst | 1 | 2020 | 79 | 0.040 |
Why?
|
| Bifidobacterium | 1 | 2021 | 70 | 0.040 |
Why?
|
| Embryo Transfer | 1 | 2020 | 61 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 130 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2021 | 208 | 0.040 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 90 | 0.040 |
Why?
|
| Ovary | 1 | 2003 | 388 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 542 | 0.040 |
Why?
|
| Cell Survival | 2 | 2015 | 889 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 1048 | 0.040 |
Why?
|
| Base Sequence | 2 | 2019 | 3172 | 0.040 |
Why?
|
| Receptors, Notch | 1 | 2021 | 214 | 0.040 |
Why?
|
| Poly I-C | 1 | 2019 | 26 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 789 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2022 | 449 | 0.040 |
Why?
|
| Motor Activity | 1 | 2003 | 539 | 0.040 |
Why?
|
| Keratin-14 | 1 | 2019 | 10 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 1093 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2012 | 1134 | 0.040 |
Why?
|
| Fruit | 1 | 2020 | 237 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2015 | 1422 | 0.040 |
Why?
|
| Aquaculture | 1 | 2018 | 9 | 0.040 |
Why?
|
| Clathrin | 1 | 2018 | 25 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 4552 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2021 | 450 | 0.040 |
Why?
|
| Hydrazones | 1 | 2018 | 19 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2023 | 1194 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 127 | 0.040 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2018 | 29 | 0.040 |
Why?
|
| Hippocampus | 1 | 2024 | 863 | 0.040 |
Why?
|
| Aminopyridines | 1 | 2018 | 60 | 0.040 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2019 | 275 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 702 | 0.040 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2018 | 48 | 0.040 |
Why?
|
| Placenta | 1 | 2002 | 535 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 318 | 0.040 |
Why?
|
| Endocytosis | 1 | 2018 | 133 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2019 | 631 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2019 | 319 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 434 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 490 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2019 | 320 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2018 | 126 | 0.030 |
Why?
|
| Gene Dosage | 2 | 2011 | 457 | 0.030 |
Why?
|
| Interleukins | 1 | 2018 | 130 | 0.030 |
Why?
|
| Models, Biological | 1 | 2002 | 1535 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 625 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2018 | 313 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 508 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 462 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 369 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2011 | 646 | 0.030 |
Why?
|
| Fresh Water | 1 | 2016 | 21 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2025 | 1717 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2018 | 367 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2016 | 93 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 93 | 0.030 |
Why?
|
| Cyclohexanones | 1 | 2015 | 19 | 0.030 |
Why?
|
| Ecosystem | 1 | 2016 | 110 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 426 | 0.030 |
Why?
|
| Herbivory | 1 | 2015 | 11 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1311 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2011 | 907 | 0.030 |
Why?
|
| Estrogen Receptor alpha | 2 | 2012 | 475 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2015 | 111 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 321 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2015 | 36 | 0.030 |
Why?
|
| Antibodies | 2 | 2009 | 382 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1044 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 248 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2019 | 2789 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 197 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 117 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2015 | 3971 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2014 | 22 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 258 | 0.030 |
Why?
|
| Synaptophysin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 247 | 0.030 |
Why?
|
| Multipotent Stem Cells | 1 | 2014 | 29 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 130 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2015 | 320 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 407 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 163 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2019 | 932 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2014 | 68 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 107 | 0.030 |
Why?
|
| Diet | 1 | 2021 | 1191 | 0.030 |
Why?
|
| Pituitary Gland | 2 | 2005 | 88 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 175 | 0.030 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2013 | 53 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 248 | 0.030 |
Why?
|
| Digoxin | 1 | 2014 | 44 | 0.030 |
Why?
|
| Epithelium | 1 | 2014 | 366 | 0.030 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 78 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2013 | 53 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2014 | 377 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 453 | 0.020 |
Why?
|
| Ovariectomy | 2 | 2004 | 188 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 57 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 357 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 1006 | 0.020 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2012 | 78 | 0.020 |
Why?
|
| Genome | 1 | 2015 | 527 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 1620 | 0.020 |
Why?
|
| Age Factors | 1 | 2018 | 2990 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2015 | 710 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 262 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 38 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 716 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 104 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 67 | 0.020 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 972 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 16 | 0.020 |
Why?
|
| Homozygote | 1 | 2012 | 561 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 346 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 42 | 0.020 |
Why?
|
| Copulation | 1 | 2009 | 10 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 362 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 329 | 0.020 |
Why?
|
| Spermatocytes | 1 | 2009 | 24 | 0.020 |
Why?
|
| Spermatids | 1 | 2009 | 27 | 0.020 |
Why?
|
| Autoantigens | 1 | 2010 | 118 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 123 | 0.020 |
Why?
|
| Oligospermia | 1 | 2009 | 61 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 254 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 703 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Cadherins | 1 | 2010 | 186 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 324 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 42 | 0.020 |
Why?
|
| Methylation | 1 | 2009 | 231 | 0.020 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2008 | 8 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 1833 | 0.020 |
Why?
|
| C-Peptide | 1 | 2009 | 116 | 0.020 |
Why?
|
| Rabbits | 1 | 2009 | 729 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 313 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 178 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 284 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1137 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 399 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1313 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9883 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 485 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 369 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2006 | 471 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 69 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 56 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 17 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 123 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 31892 | 0.010 |
Why?
|
| Carcinogens | 1 | 2005 | 160 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2009 | 1497 | 0.010 |
Why?
|
| Complement C3 | 1 | 2005 | 54 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2004 | 32 | 0.010 |
Why?
|
| Haploidy | 1 | 2004 | 21 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1625 | 0.010 |
Why?
|
| Prostate | 1 | 2007 | 448 | 0.010 |
Why?
|
| Lactoferrin | 1 | 2005 | 78 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 772 | 0.010 |
Why?
|
| Sperm Count | 1 | 2004 | 90 | 0.010 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 142 | 0.010 |
Why?
|
| Death | 1 | 2004 | 80 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 2003 | 54 | 0.010 |
Why?
|
| Digestive System | 1 | 2003 | 65 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2007 | 616 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2003 | 125 | 0.010 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.010 |
Why?
|
| Embryo Loss | 1 | 2002 | 26 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 537 | 0.010 |
Why?
|
| Placentation | 1 | 2002 | 61 | 0.010 |
Why?
|
| Ligation | 1 | 2002 | 137 | 0.010 |
Why?
|
| Child | 1 | 2022 | 25780 | 0.010 |
Why?
|
| Spermatozoa | 1 | 2004 | 244 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 616 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 293 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 397 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 451 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 249 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 257 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 522 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 897 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 522 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2009 | 6592 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2002 | 922 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 13007 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6583 | 0.010 |
Why?
|
| Brain | 1 | 2003 | 3226 | 0.010 |
Why?
|
| Middle Aged | 1 | 2009 | 29314 | 0.000 |
Why?
|